Neurogene awards inducement stock options for 38,330 shares to new hires

Neurogene granted non-qualified stock options covering 38,330 common shares to two newly hired employees on Sept. 1, 2026.

• The exercise price was set at the stock’s closing price on the grant date.
• The awards vest over four years, with 25% vesting after one year.
• The remaining options vest monthly at 1/48 per month over the next three years, contingent on continued employment.